369 related articles for article (PubMed ID: 2830582)
21. Gene expression profiling of fibroblasts resistant toward oncogene-mediated transformation reveals preferential transcription of negative growth regulators.
Tchernitsa OI; Zuber J; Sers C; Brinckmann R; Britsch SK; Adams V; Schäfer R
Oncogene; 1999 Sep; 18(39):5448-54. PubMed ID: 10498898
[TBL] [Abstract][Full Text] [Related]
22. [Constitutive activity of MAP kinase cascades in REF cells transformed by E1A and cHa-ras oncogenes].
Svetlikova SB; Abramova MV; Kukushkin AN; Darieva ZA; Pospelova TV; Pospelov VA
Tsitologiia; 2001; 43(10):961-8. PubMed ID: 11769129
[TBL] [Abstract][Full Text] [Related]
23. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
24. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
25. Anisomycin abrogates repression of protooncogene c-fos transcription in E1A + cHa-ras-transformed cells through activation of MEK/ERK kinase cascade.
Kukushkin AN; Svetlikova SB; Amanzholov RA; Pospelov VA
J Cell Biochem; 2008 Feb; 103(3):1005-12. PubMed ID: 17647273
[TBL] [Abstract][Full Text] [Related]
26. Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein.
Subramanian T; La Regina M; Chinnadurai G
Oncogene; 1989 Apr; 4(4):415-20. PubMed ID: 2524023
[TBL] [Abstract][Full Text] [Related]
27. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
[TBL] [Abstract][Full Text] [Related]
28. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
[TBL] [Abstract][Full Text] [Related]
29. Activated fos oncogene in rat embryo fibroblasts transformed by ras and myc oncogenes.
Denner J; Jandrig B; Spitkovsky DD; Ehm I; Kisselyov FL; Schramm T
Neoplasma; 1988; 35(3):263-70. PubMed ID: 3405335
[TBL] [Abstract][Full Text] [Related]
30. Oncogene-induced liver neoplasia in transgenic mice.
Sandgren EP; Quaife CJ; Pinkert CA; Palmiter RD; Brinster RL
Oncogene; 1989 Jun; 4(6):715-24. PubMed ID: 2543942
[TBL] [Abstract][Full Text] [Related]
31. Transformation of human embryo retinoblasts with simian virus 40, adenovirus and ras oncogenes.
Gallimore PH; Grand RJ; Byrd PJ
Anticancer Res; 1986; 6(3 Pt B):499-508. PubMed ID: 3017183
[TBL] [Abstract][Full Text] [Related]
32. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
[TBL] [Abstract][Full Text] [Related]
33. Differential induction of cytolytic susceptibility by E1A, myc, and ras oncogenes in immortalized cells.
Cook JL; May DL; Wilson BA; Walker TA
J Virol; 1989 Aug; 63(8):3408-15. PubMed ID: 2526229
[TBL] [Abstract][Full Text] [Related]
34. Requirement of the C-terminal region of adenovirus E1a for cell transformation in cooperation with E1b.
Subramanian T; Malstrom SE; Chinnadurai G
Oncogene; 1991 Jul; 6(7):1171-3. PubMed ID: 1830644
[TBL] [Abstract][Full Text] [Related]
35. Forskolin and a tumor promoter are able to induce c-fos and c-myc expression in normal, but not in a v-ras-transformed rat thyroid cell line.
Colletta G; Cirafici AM; Consiglio E; Vecchio G
Oncogene Res; 1987; 1(4):459-66. PubMed ID: 3329719
[TBL] [Abstract][Full Text] [Related]
36. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
[TBL] [Abstract][Full Text] [Related]
37. myc and E1A oncogenes alter the responses of PC12 cells to nerve growth factor and block differentiation.
Maruyama K; Schiavi SC; Huse W; Johnson GL; Ruley HE
Oncogene; 1987; 1(4):361-7. PubMed ID: 2838784
[TBL] [Abstract][Full Text] [Related]
38. A nonkaryophilic T antigen of SV40 can either immortalize or transform rodent cells, and cooperates better with cytoplasmic than with nuclear oncoproteins.
Fischer-Fantuzzi L; Vesco C
Oncogene Res; 1987 Aug; 1(3):229-42. PubMed ID: 2835734
[TBL] [Abstract][Full Text] [Related]
39. Cellular oncogenes and lymphocyte activation.
Schneider-Schaulies J; Knauer R; Schimpl A; Wecker E
Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
[TBL] [Abstract][Full Text] [Related]
40. Oncogene-mediated transformation of fetal rat colon in vitro.
Pories S; Jaros K; Steele G; Pauley A; Summerhayes IC
Oncogene; 1992 May; 7(5):885-93. PubMed ID: 1373876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
